Key facts
- BreachRx’s last known valuation is $52.0M (May 2025).
- It has raised $23.9M; the latest was Later Stage VC ($15.0M) in May 2025.
- Notable investors include Plug and Play Tech Center, Alchemist Accelerator, Overline, SYN Ventures, Ballistic Ventures (California) — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for BreachRx
- ·The full record, as it builds
Funding rounds
No funding rounds for BreachRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BreachRx
Developer of an intelligent incident response platform designed to provide operational resilience for the entire enterprise. The company's platform offers automatically generated incident response plans, targeted stakeholder guidance, integrated privileged communication channels, and audit trails, enabling enterprises to maintain compliance and protect leadership from personal liability.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 35
- Website
- breachrx.com/
- Ownership
- Privately Held (backing)
BreachRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BreachRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BreachRx in its N-PORT filings yet. We sweep new filings monthly.